Exchange: NASDAQ·Updated 07:30 PM EDT
KRRO logo

KRRO Korro Bio Inc

$9.57
$0.00
(0.00%)
Today
Closed $9.57
$0.00
(0.00%)
After Hours
EarningsNov 12
Mkt Cap$140.92M
Vol114,420.00

About KRRO

Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B. Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.
49

Neutral Sentiment

How do you feel about KRRO?

Advertisement|Remove ads.